This is a working overview of hGH fragment, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; visual inspection |
| Solubility | Soluble in water and aqueous buffers | Depends on pH, purity, and counterion |
| Typical storage | -20 °C or below, desiccated | Protect from light; avoid repeated freeze-thaw after reconstitution |
| Common analytical method | Reversed-phase HPLC and mass spectrometry | Purity by HPLC; identity and mass by LC-MS or MALDI-TOF |
| Common synonyms | hGH fragment 176–191; AOD-9604 | Names vary in research and product labeling |
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
In the scientific literature, AOD-9604 appears in reviews of growth hormone fragments and in discussions of peptide-based metabolic research. Some sources distinguish it from growth hormone itself, while others group it with compounds marketed for weight management. The evidence base is small compared with approved obesity medications. Questions about long-term efficacy and clinical relevance remain open, and independent replication of key findings is limited. Most published reports are early-stage and exploratory.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It is often described as hGH fragment 176-191. Research interest arose because it was designed to isolate possible effects on fat metabolism from other actions of growth hormone. It is not a full growth hormone molecule. Its development history includes early laboratory and animal studies followed by human trials. The peptide has been examined in laboratory, animal, and limited human studies.
US–South African relations took an unexpected turn with Ronald Reagan's electoral victory in the 1980 US presidential elections. Reagan's tough anti-communist record and rhetoric was greeted with cautious optimism by Pretoria; during his election campaign he'd described the geopolitical situation in southern Africa as "a Russian weapon" aimed at the US. President Reagan and his Assistant Secretary of State for African Affairs Chester Crocker adopted a policy of constructive engagement with the Botha government, restored military attachés to the US embassy in South Africa, and permitted SADF officers to receive technical training in the US. They believed that pressure tactics against South Africa would be contrary to US regional goals, namely countering Soviet and Cuban influence. In a private memo addressed to the South African foreign minister, Crocker and his supervisor Alexander Haig declared that "we [the US] share your view that Namibia must not be turned over to the Soviets and their allies. A Russian flag in Windhoek is as unacceptable to us as it is to you". Washington also ended its condemnation of SADF cross-border raids, which was perceived as tacit support for the latter's actions in Angola and elsewhere. This had the effect of encouraging Botha to proceed with larger and increasingly more ambitious operations against PLAN. Between 1980 and 1982 South African ground forces invaded Angola three times to destroy the well-entrenched PLAN logistical infrastructure near the border region.
molecular cloning Any of various molecular biology methods designed to replicate a particular molecule, usually a DNA sequence or a protein, many times inside the cells of a natural host. Commonly, a recombinant DNA fragment containing a gene of interest is ligated into a plasmid vector, which competent bacterial cells are then induced to uptake in a process known as transformation. The bacteria, carrying the recombinant plasmid, are then allowed to proliferate naturally in cell culture, so that each time the bacterial cells divide, the plasmids are replicated along with the rest of the bacterial genome. Any functioning gene of interest within the plasmid will be expressed by the bacterial cells, and thereby its gene products will also be cloned. The plasmids or gene products, which now exist in many copies, may then be extracted from the bacteria and purified. Molecular cloning is a fundamental tool of genetic engineering employed for a wide variety of purposes, often to study gene expression, to amplify a specific gene product, or to generate a selectable phenotype.
In the context of the fall of communism throughout Eastern Europe during the revolutions of 1989, a protest in support of Reformed pastor László Tőkés that began in December 1989 in Timișoara quickly escalated into a national uprising against the communist regime, ultimately resulting in the execution of Ceaușescu and his wife Elena on 25 December 1989. An interim council composed of figures from civil society and former communist officials assumed control of the government, and Ion Iliescu became the provisional president of the country. The new government reversed many of the authoritarian communist policies and dismissed several leaders of the former regime, although still influenced by members of the former regime (the basis for the Golaniad, and Mineriads). In May 1990, the first free elections in Romania since the 1937 elections were held, with Iliescu of the National Salvation Front winning the presidency with 85% of the vote. In 1992, he was reelected in the first election after the adoption of a permanent constitution via a referendum held the previous year. Illiescu lost the 1996 election to Emil Constantinescu, but returned to power in 2000. Traian Băsescu was elected president in 2004 and 2009, serving until 2014 at which point Klaus Iohannis succeeded him, being re-elected in 2019 and serving until 2025. During these years several events occurred. In 2009, the country was bailed out by the International Monetary Fund as result of the Great Recession in Europe following the 2008 financial crisis.
Reported impairments range from short-term memory deficits to long-term memory difficulties, including deficits in episodic (memory of one's life), procedural (memory of the body of how to perform an activity), and working memory. Reported neuropsychiatric signs are anxiety, depression, a reduced display of emotions, egocentrism, aggression, and compulsive behavior and hallucination and delusion. Other common psychiatric disorders could include obsessive–compulsive disorder, mania, insomnia and bipolar disorder. Difficulties in recognizing other people's negative expressions have also been observed. The prevalence of these symptoms is highly variable between studies, with estimated rates for lifetime prevalence of psychiatric disorders between 33 and 76%. For many with the disease and their families, these symptoms are among the most distressing aspects of the disease, often affecting daily functioning and constituting reason for institutionalization. Early behavioral changes in HD result in an increased risk of suicide. Often, individuals have reduced awareness of chorea, cognitive, and emotional impairments.
=== Spinal drainage theory === Some studies have proposed that issues with the spinal venous drainage system may cause a CSF leak. According to this theory, dural holes and intracranial hypotension are symptoms caused by low venous pressure in the epidural space. When leg muscles pump blood towards the heart, and pressure in the inferior vena cava vein becomes negative, the network of epidural veins is overdrained, causing CSF to be aspirated into the epidural space. True leaks can form at weak points in the spinal meninges. Therefore, the observed CSF hypotension is a result of CSF hypovolemia and reduced epidural venous pressure.
Sources: en.wikipedia.org
=== Chemical === Different chemical procedures for the conversion into final products or the removal of pollutants are used for the safe disposal of contaminants. Pre-chlorination for algae control and arresting biological growth. Aeration along with pre-chlorination for removal of dissolved iron when present with relatively small amounts of manganese. Disinfection for killing bacteria, viruses and other pathogens, using chlorine, ozone and ultra-violet light.
=== Other === Mamman Shata – Legendary Hausa-singer from Katsina State. Sunusi Ibrahim – Footballer Dadasare Abdullahi – Writer, Teacher and first female journalist from Northern Nigeria. Hajiya Ma'daki - Nigerian noblewoman and advisor in the royal courts of Katsina and Kano. Aisha Buhari – former First Lady of Nigeria. Maryam Uwais - Lawyer, Human Right Activist. Bello Bala Shagari – Documentary filmmaker, a Youth Activist & Leader and the Current president of The National Youth Council of Nigeria (NYCN), Nigeria. Yakubu Muhammed Hausa actor.
Negative selection (background depletion or subtraction) targets and eliminates the host and microbiome genomic background, while aiming to preserve the nucleic acid derived from the pathogens of interest. Degradation of genomic background can be performed through broad-spectrum digestion with nucleases, such as DNase I for DNA background, or by removing abundant RNA species (rRNA, mtRNA, globin mRNA) using sequence-specific RNA depletion kits. Also CRISPR-Cas9-based approaches can be performed to target and deplete human mitochrondrial RNA for example. Generally, however, subtraction approaches lead to a certain degree of loss of the targeted pathogen genome, as poor recovery may occur during the cleanup. Positive enrichment is used to increase pathogen signal rather than reducing background noise. This is commonly done through hybridization-based target capture by probes, which are used to pull out nucleic acid of interest for downstream amplification and sequencing. Panviral probes have been shown to successfully identify diverse types of pathogens in different clinical fluid and respiratory samples, and have been used for sequencing and characterization of novel viruses. However, the probe approach includes extra hybridization and cleanup steps, requiring higher sample input, increasing the risk of losing the target, and increasing the cost and hands-on time. High-throughput sequencing: all the nucleic acids fragments of the library are sequenced.
The procedure is illustrated by the synthesis of a dipeptide library using the same three amino acids as building blocks in both cycles. Each component of this library contains two amino acids arranged in different orders. The amino acids used in couplings are represented by yellow, blue and red circles in the figure. Divergent arrows show the division of solid support resin (green circles) into equal portions, vertical arrows mean coupling, and convergent arrows represent the mixing and homogenizing of the portions of the support. The figure shows that, in the two synthetic cycles, 9 dipeptides are formed. In the third and fourth cycles, 27 tripeptides and 81 tetrapeptides would form respectively. The "split-mix synthesis" has several outstanding features:
Sources: en.wikipedia.org
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.
Mass spectrometry, such as LC-MS or MALDI-TOF, confirms the molecular mass and can reveal sequence-related impurities. Reversed-phase HPLC is used for purity, and peptide mapping or amino acid analysis can support sequence identity. No single method establishes every quality attribute.
No. AOD9604 is a short synthetic fragment of the hGH sequence, not the full 191-amino-acid hormone. It lacks the regions that mediate hGH receptor activation and growth-promoting effects. Products labeled as AOD9604 should not be assumed to have the same properties as hGH.
AOD9604 is a synthetic peptide based on a C-terminal segment of human growth hormone. It is manufactured by chemical peptide synthesis rather than extracted from human tissue. The sequence is often described as hGH fragment 176–191 or a close variant.